EventsThe 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response
Event submissions
Published
with-doi10.3390/IECC2021-09207
This submission belongs to the session 8. Poster of the event The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response
Published date
29 Jan, 2021
Citation
Haitang Yang, Beibei Sun, Sean R R R. R. Hall, Ke Xu, Liang Zhao, Ralph A. Schmid, Ren-Wang Peng, Feng Yao, Responsive signatures established by pharmaco-transcriptomic correlation analysis identifies subsets for PARP-targeted therapy and reveals potential synergistic interactors, in Proceedings of The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response, 1 February–14 February 2021, MDPI: Basel, Switzerland, doi: 10.3390/IECC2021-09207
Share
Email
Facebook
Twitter
LinkedIn

Responsive signatures established by pharmaco-transcriptomic correlation analysis identifies subsets for PARP-targeted therapy and reveals potential synergistic interactors

image
Haitang Yang 1
Beibei Sun 2
Sean R R R. R. Hall 3
Ke Xu 1
Liang Zhao 4
Ralph A. Schmid 4
image
Ren-Wang Peng 4
Feng Yao 1
1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
2. Institute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
3. Gillies McIndoe Research Institute, Wellington, New Zealand.
4. Division of General Thoracic Surgery, Department of BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Switzerland.
Abstract
Keywords
PARP targeted therapy
gene signature
pharmaco-transcriptomics
low-grade glioma
small cell lung cancer
Manuscript
Yang, et al-manuscript-2021.01.20.pdf
Poster
sciforum-041460.pdf
sciforum-041460.pdf